Acute Kidney Problems in Congestive Heart Failure

Chapter
First Online:

Abstract

In cardiac failure, arterial underfilling leads to neurohumeral activation and renal sodium and water retention, thus increasing both the preload and afterload, potentially setting up a vicious cycle leading to a cardiorenal syndrome. During acute decompensated heart failure, a deterioration in renal function is associated with a markedly increased risk of patient mortality.

Keywords

Chronic Kidney Disease Acute Kidney Injury Brain Natriuretic Peptide Renal Artery Stenosis Acute Decompensated Heart Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Anand IS, Kuskowski MA, Rector TS et al. (2005) Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation 112:1121–1127.CrossRefPubMedGoogle Scholar
  2. 2.
    Chen HH, Schrier RW (2006) Pathophysiology of volume overload in acute heart failure syndromes. Am J Med 119:S11–S16.CrossRefPubMedGoogle Scholar
  3. 3.
    Costanzo MR, Guglin ME, Saltzberg et al. (2007) Ultra­filtration versus intravenous diuretics for patients ­hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49:675–683.CrossRefPubMedGoogle Scholar
  4. 4.
    Forman DE, Butler J, Wang Y et al. (2004) Incidence, predictors at admission and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43:61–67.CrossRefPubMedGoogle Scholar
  5. 5.
    Funabiki K, Masuoka H, Shimizu H et al. (2003) Cholesterol crystal embolization (CCE) after cardiac catheterization: a case report and a review of 36 cases in the Japanese literature. Jpn Heart J 44:767–774.CrossRefPubMedGoogle Scholar
  6. 6.
    Gheorghiade M, Niazi I, Ouyang J et al. (2003) Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation 107:2690–2696.CrossRefPubMedGoogle Scholar
  7. 7.
    Goldsmith SR (2006) Is there a cardiovascular rationale for the use of combined vasopressin V1a/V2 receptor antagonists? Am J Med 119(Suppl 1):S93–S96.CrossRefPubMedGoogle Scholar
  8. 8.
    Gottlieb SS, Brater DC, Thomas I et al. (2002) BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 105:1348–1353.CrossRefPubMedGoogle Scholar
  9. 9.
    Felker GM, Adams KF Jr, Konstam MA et al. (2003) The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J 145(Suppl 2):S18–25.CrossRefPubMedGoogle Scholar
  10. 10.
    Heywood JT, Fonarow GC, Costanzo MR et al. (2007) High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 13:422–430.CrossRefPubMedGoogle Scholar
  11. 11.
    Iglesias J, Hom D, Antoniotti M et al. (2006) Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide). Nephrol Dial Transplant 21:3458–3465.CrossRefPubMedGoogle Scholar
  12. 12.
    Januzzi JL Jr, Camargo A, Anwarruddin S et al. (2005) The N terminal pro-BNP investigation of dyspnoea in the emergency department (PRIDE) study. Am J Cardiol 95: 1625–1633.Google Scholar
  13. 13.
    Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007–2018.CrossRefPubMedGoogle Scholar
  14. 14.
    Juurlink DN, Mamdani MM, Lee DS et al. (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 351:543–551.CrossRefPubMedGoogle Scholar
  15. 15.
    Kalra P, Guo H, Kausz AT et al. (2005) Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kid Int 62:293–301.CrossRefGoogle Scholar
  16. 16.
    Kingdon EJ, Holt SG, Davar J et al. (2001) Atrial thrombus and central venous dialysis catheters. Am J Kidney Dis 38: 631–639.CrossRefPubMedGoogle Scholar
  17. 17.
    Krumholz HM, Chen Y-T, Vaccarino V et al. (2000) Correlates and impacts on outcomes of worsening renal function in patients ≥ 65 years of age with heart failure. Am J Cardiol 139:72–77.Google Scholar
  18. 18.
    Libetta C, Sepe V, Zucchi M et al. (2007) Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines. Nephrol Dial Transplant 22:2013–2019.CrossRefPubMedGoogle Scholar
  19. 19.
    Maisel AS, Krishnaswamy P, Nowak RM et al. (2002) Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167.CrossRefPubMedGoogle Scholar
  20. 20.
    Maisel AS, Krishnaswamy P, Nowak RM et al. (2004) BNP Multinational Study Investigators. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J 147:1078–1084.CrossRefPubMedGoogle Scholar
  21. 21.
    Palmer BF (2002) Renal dysfunction complicating the treatment of hypertension. N Engl J Med 347:1256–1261.CrossRefPubMedGoogle Scholar
  22. 22.
    Saltzman HE, Sharma K, Mather PJ et al. (2007) Renal dysfunction in heart failure patients: what is the evidence ? Heart Fail Rev 12:37–47.CrossRefPubMedGoogle Scholar
  23. 23.
    Schrier RW (2007) Cardiorenal versus renocardiac syndrome: is there a difference? Nat Clin Pract Nephrol. 3:637.CrossRefPubMedGoogle Scholar
  24. 24.
    Takahashi T, Konta T, Nishida W et al. (2003) Renal cholesterol embolic disease effectively treated with steroid pulse therapy. Intern Med 42:1206–1209.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Royal Free HospitalLondonUK

Personalised recommendations